Pangaea Data and Topcon Healthcare announce strategic investment
The partnership aims to accelerate Pangaea’s efforts to address critical care gaps in eye health and systemic disease.
Pangaea’s AI platform PALLUX works to automatically analyze structured and unstructured patient records against clinical guidelines. Image credit: AdobeStock/Johnstocker
Health artificial intelligence (AI) company Pangaea Data has announced a strategic investment from Topcon Healthcare which aims to accelerate Pangaea’s efforts to address critical care gaps in eye health and systemic disease.1 These efforts include utilizing Pangaea’s clinically validated AI platform PALLUX, according to a news release.
“We are thrilled to partner with Topcon Healthcare to scale our platform’s reach and improve timely diagnosis and treatment across eye care,” said Vibhor Gupta, PhD, founder and CEO of Pangaea Data, in the release. “Together, we can empower providers to close care gaps while generating actionable insights for population health, discovery science, and value-based care.”
Pangaea’s AI platform works to automatically analyze structured and unstructured patient records against clinical guidelines. By emulating a clinician’s manual review, the structure can then uncover patients who meet diagnostic or treatment criteria that are not currently in the treatment or management process. The platform is also integrated into existing EHR and downstream scheduling systems, allowing for real-time clinical review.1
“Pangaea Data’s unique ability to find missed patients using AI, and to do so without burdening clinicians, has powerful implications for eye care and beyond,” said Ali Tafreshi, CEO and president of Topcon Healthcare, in the release. “This partnership supports our Healthcare from the Eye™ initiative, which uses ocular data and AI to transform how systemic and ocular diseases are detected and managed. We are proud to support Pangaea Data’s mission through this strategic investment.”
The partnership will allow Topcon to utilize PALLUX within its Harmony digital health platform so that optometry and ophthalmology practices can access patient information in order to identify those needing follow up or further evaluation.1 Patients with conditions such as glaucoma and diabetic retinopathy can be identified through the interface, according to the release.
The partnership also signals the company’s expansion into eye care, as it is already used in therapeutic areas such as pulmonology, cardiology, oncology, nephrology, and infectious diseases.1 Pangaea states that PALLUX has an easy deployment in practices of 8-12 weeks with infrastructure that supports HL7 FHIR. The platform is also compliant with health care regulations, as it is not classified as SaMD and is compliant with HIPAA and GDPR standards.2
In late 2024, Pangaea had been selected for NVIDIA and Microsoft’s AI initiative that included a first cohort of 5 companies. The initiative combines the NVIDIA Inception global program for startups and Microsoft for Startups and works to broaden access to accelerated computing for included startups. This includes providing cloud credits, software for AI development, and the support of technical and business experts.3
Pangaea has had an extensive history thus far working with Microsoft. In late 2022, Pangaea was awarded top tier co-sell partnership status by Microsoft, which is the company’s highest level partner designation. Through the partnership, Pangaea has been able to work with Microsoft’s sales organization to accelerate the sales and usage of Pangaea’s AI platform on Microsoft Azure.4
References:
Pangaea Data secures strategic investment from Topcon Healthcare, Inc to close global care gaps in eye health. News release. Topcon Healthcare. May 27, 2025. Accessed May 28, 2025. https://topconhealthcare.com/article/pangaea-data-secures-strategic-investment-from-topcon-healthcare-inc-to-close-global-care-gaps-in-eye-health/
Panaea Data’s PALLUX platform. Pangaea Data. Accessed May 28, 2025. https://www.pangaeadata.ai/product/
Pangaea Data selected for NVIDIA and Microsoft’s new AI initiative. News release. Pangaea Data. 2024. Accessed May 29, 2025. https://www.pangaeadata.ai/2024/11/05/nvidia-microsoft-initiative/
Pangaea Data awarded top tier co-sell partnership status by Microsoft. News release. November 7, 20222. Accessed May 28, 2025. https://www.pangaeadata.ai/2022/11/07/pangaea-data-awarded-top-tier-co-sell-partnership-status-by-microsoft/
Newsletter
Want more insights like this? Subscribe to Optometry Times and get clinical pearls and practice tips delivered straight to your inbox.
